(LeustatinTM, 2-CdA, 2-Chlorodeoxyadenosine)
Cladribine is used to treat hairy cell leukemia, chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphomas.
Cladribine is administered by infusion through a vein. The infusion may be over 1-2 hours on consecutive days, or may be as a continuous infusion over several days. The way it is given depends on the protocol.